FDA Civil Monetary Penalties Increase Across the Board to Keep Pace with Inflation Post author:Sam Post published:February 2, 2017 Post category:Drug Industry Daily The FDA’s civil monetary penalties are increasing to adjust for inflation at under 2 percent. Source: Drug Industry Daily You Might Also Like PTO Grants Additional Reviews of Herceptin Patents after Hospira Challenges July 31, 2017 Woodcock Introduces New Quality Metrics Programs July 27, 2018 Insurers, Advocacy Groups Urge FDA to Finalize Biosimilar Guidance August 24, 2018